Outlook Therapeutics
OTLK
OTLK
63 hedge funds and large institutions have $50.2M invested in Outlook Therapeutics in 2021 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 14 closing their positions.
Holders
63
Holders Change
+14
Holders Change %
+28.57%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
11
Reduced
15
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$14.3M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$3.34M |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$3.78M |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$2.19M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$11.5M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VFA
76
Valeo Financial Advisors
Carmel,
Indiana
| – | – | -1,000 | Closed |
|
77
Wells Fargo
San Francisco,
California
| $0 | 31 | -585 | -95% |
|